TARDBP and amyotrophic lateral sclerosis: Previous data from our lab demonstrated the efficacy of IGS2.7 to restore the homeostasis of TARDBP in lymphoblasts from ALS patients and in the TDP-43A315T mouse model through CK1 inhibition [21].